Literature DB >> 5771186

Binding of digitoxin and some related cardenolides to human plasma proteins.

D S Lukas, A G De Martino.   

Abstract

Tritium-labeled digitoxin, digitoxigenin, digoxin, and digoxigenin of established purity and chemcal authenticity were used to study the binding of these compounds to human plasma proteins. 97% of digitoxin in plasma was nondialyzable. Continuous flow paper electrophoresis of plasma containing digitoxin and dialysis experiments in which human serum albumin competed for the glycoside with plasma or plasma protein fractions demonstrated that digitoxin was almost exclusively bound by albumin. Equilibrium dialyses revealed that the interaction was characterized by a single binding site on the albumin molecule and an association constant of 9.62 x 10(4) liter/mole at 37 degrees C. At 1 degrees C the association constant was 4.64 x 10(4) liter/mole. The interaction therefore was endothermic; the gain in enthalpy of 3.5 kcal/mole and the free energy change of - 7.06 kcal/mole was derived from a large change in entropy of 33.8 cal/mole per degrees K. The direction of these thermodynamic changes suggested the formation of a hydrophobic bond between digitoxin and albumin. Quenching of the fluorescence of albumin by digitoxin indicated that the conformation of albumin was altered by the binding process.Digitoxigenin, its mono- and didigitoxosides, digoxin, and digoxigenin competed with digitoxn for its binding site on albumin. The affinity of the mono- and didigitoxosides for the site was equal to that of digitoxin, but that of digitoxigenin was only one-third as great. The ability of the digitoxose residues of the glycosides to enhance binding to albumin was also observed with digoxin, which was more extensively bound by the protein than digoxigenin. At concentrations of 2 mug/ml or less in plasma, only 23% of digoxin was bound. Albumin, which interacted with digoxin with an apparent association constant of 9 x 10(2) liter/mole at 37 degrees C, was entirely responsible for the binding. Lowering the temperature from 37 degrees to 1 degrees C decreased the fraction of digoxin bound to albumin by two-thirds. The marked difference in avidity of digitoxin and digoxin for serum albumin is reflected by the higher plasma concentrations, lower rate of urinary excretion, and longer half-time of digitoxin as compared to those of digoxin when these compounds are administered to man.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5771186      PMCID: PMC322318          DOI: 10.1172/JCI106060

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  ENZYMATIC BASIS FOR EPIMERIZATION OF CARDIOTONIC STEROIDS AT CARBON 3 IN RAT LIVER.

Authors:  K REPKE; L T SAMUELS
Journal:  Biochemistry       Date:  1964-05       Impact factor: 3.162

2.  THE COTTON EFFECTS IN THE OPTICAL ROTATORY DISPERSION OF PROTEINS AS NEW CRITERIA OF CONFORMATION.

Authors:  B JIRGENSONS
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

3.  THE BINDING OF ANDROSTERONE SULFATE, ETHIOCHOLANOLONE SULFATE, AND DEHYDROISOANDROSTERONE SULFATE BY HUMAN PLASMA PROTEIN.

Authors:  J E PLAGER
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

4.  Some quantitative aspects of the binding of quinidine and related quinoline compounds by human serum albumin.

Authors:  H L CONN; R J LUCHI
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

5.  Protein binding radioactive digitoxin.

Authors:  J L SPRATT; G T OKITA
Journal:  J Pharmacol Exp Ther       Date:  1958-10       Impact factor: 4.030

6.  Testosterone binding to bovine and human serum albumin: the role of tyrosine groups.

Authors:  E K OYAKAWA; B H LEVEDAHL
Journal:  Arch Biochem Biophys       Date:  1958-03       Impact factor: 4.013

7.  The binding of thyroxine by serum albumin as measured by fluorescence quenching.

Authors:  R F Steiner; J Roth; J Robbins
Journal:  J Biol Chem       Date:  1966-02-10       Impact factor: 5.157

8.  Steroid-protein interaction with particular reference to testosterone binding by human serum.

Authors:  W H Pearlman; O Crépy
Journal:  J Biol Chem       Date:  1967-01-25       Impact factor: 5.157

9.  Fluorescence spectra of human serum albumin in the pH region of the N-F transition.

Authors:  R F Chen
Journal:  Biochim Biophys Acta       Date:  1966-05-12

10.  Administration of tritiated digoxin with and without a loading dose. A metabolic study.

Authors:  F I Marcus; L Burkhalter; C Cuccia; J Pavlovich; G G Kapadia
Journal:  Circulation       Date:  1966-11       Impact factor: 29.690

View more
  31 in total

1.  Some clinical implications of the protein binding of digoxin.

Authors:  S Wallace; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

2.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  Distribution and elimination of digoxin in infants.

Authors:  G Wettrell
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

4.  Clinical pharmacokinetics of digitoxin.

Authors:  D Perrier; M Mayersohn; F I Marcus
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 5.  Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Authors:  P Kramer
Journal:  Klin Wochenschr       Date:  1977-01-01

6.  Serum digoxin by radioimmunoassay.

Authors:  R J Hoeschen; V Proveda
Journal:  Can Med Assoc J       Date:  1971-07-24       Impact factor: 8.262

Review 7.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 8.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 9.  Protein binding of cardiac glycosides in disease states.

Authors:  L Storstein
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

10.  Metabolism of digitoxin in man and its modification by spironolactone.

Authors:  K E Wirth; J C Frölich; J W Hollifield; F C Falkner; B S Sweetman; J A Oates
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.